Ocumension Therapeutics (HKSE:01477) Price-to-Operating-Cash-Flow : (As of Apr. 26, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-04-26), Ocumension Therapeutics's share price is HK$6.47. Ocumension Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.46. Hence, Ocumension Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Ocumension Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:01477's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.725
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Ocumension Therapeutics's Cash Flow from Operations per share for the six months ended in Jun. 2023 was HK$-0.20. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.46.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -19.20% per year.

During the past 6 years, Ocumension Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was -19.20% per year. The lowest was -66.50% per year. And the median was -42.85% per year.

Ocumension Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Ocumension Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Price-to-Operating-Cash-Flow Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Ocumension Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Ocumension Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocumension Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocumension Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ocumension Therapeutics's Price-to-Operating-Cash-Flow falls into.

Ocumension Therapeutics Price-to-Operating-Cash-Flow Calculation

Ocumension Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	6.47	/	-0.463
	=

Ocumension Therapeutics's Share Price of today is HK$6.47.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ocumension Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.46.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Ocumension Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (HKSE:01477) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (HKSE:01477) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

5DG:Germany

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (HKSE:01477) Headlines

No Headlines